Pang, Yilin
Xu, Xianxian
Li, Daizhi
Ge, Yue
Liang, Jiamin
Xiong, Xiaojun
Wen, Shaohuai
Li, Xiaokai
Wang, Yueqiu
Li, Xiongying
Tan, Guoqiang
Lin, Yuanshan https://orcid.org/0000-0002-1637-8353
Funding for this research was provided by:
Innovation Platform Open Fund Project of Colleges and Universities of Hunan Province (19k045)
Key Discipline of Zhejiang Province in Medical Technology (first class)
Key Discipline of Zhejiang Province in Medical Technology (category A)
The double first-class construction project of Hunan Agricultural University (SYL201802003)
Article History
Received: 3 December 2024
Revised: 23 June 2025
Accepted: 29 June 2025
First Online: 27 October 2025
Declarations
:
: All animal care procedures and experimental protocols adhered to the National Institutes of Health guidelines (Bethesda, MD, USA) and received approval from the Experimental Animal Ethics and Welfare Committee of Hunan Animal Pharmaceutical Company (Approval Number: IACUC HAPC 2021–121-01).
: Authors YLP, JML, XJX, SHW, YQW, and XYL were employed by Hunan Animal Pharmaceutical Company, Hunan New Wellful Company Limited, Hunan Agricultural Group Company, and Hunan Agricultural Development & Investment Group Company. The authors declare no competing interests.